At The Iskandar Complex Hernia Center, where innovation and surgical excellence go hand-in-hand, a groundbreaking study out ...

The first patient in the U.S. has been dosed with a novel radioactive medicine to treat advanced breast cancer as part of an international clinical trial.

Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of an international multisite clinical trial.

These include the estrogen receptor alpha (ERα). Its high plasticity makes it very dangerous. It has a poor outlook. But new research offers hope. Scientists found a way to target this plasticity.

Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of ...

New research is showing promise that a vaccine may be able to fight one type of the most common cancers in women. Phase one ...

A new male birth control pill has passed early safety trials, showing promise with minimal side effects. Larger human trials ...

Patients on Itovebi plus Ibrance and fulvestrant had improved progression-free and overall survival compared to Ibrance-fulvestrant alone.

Tight control of separase activity is essential for prolonged meiotic arrest of mammalian oocytes. Here, removal of securin and cyclin B1-Cdk1 dual inhibition of separase in mouse oocytes leads to ...